Gynecomastia after chemotherapy for lymphoma

Area of Science:

• Oncology
• Endocrinology

Background:

• Gynecomastia development in cancer patients can suggest tumor recurrence.
• This study investigates gynecomastia in lymphoma patients undergoing chemotherapy.

Observation:

• Three lymphoma patients developed gynecomastia during or after chemotherapy.
• Hormonal profiles showed normal testosterone, high-normal to elevated LH, and elevated FSH.
• One patient had transiently elevated estradiol that normalized with spontaneous gynecomastia resolution.

Findings:

• Gynecomastia in these cases did not correlate with a negative prognosis.
• Spontaneous resolution occurred in one patient off therapy.
• Resolution also occurred during maintenance chemotherapy in another patient.

Implications:

• Gynecomastia following lymphoma chemotherapy is not necessarily an ominous sign.
• It may not require treatment regimen alteration.
• Further research into the specific mechanisms of chemotherapy-induced gynecomastia is warranted.